Phosphatidylinositol 3-kinase hyperactivation results in lapatinib resistance that is reversed by the mTOR/phosphatidylinositol 3-kinase inhibitor NVP-BEZ235.

Source:http://linkedlifedata.com/resource/pubmed/id/19010894

Cancer Res. 2008 Nov 15 68 22 9221-30

Download in:

View as

General Info

PMID
19010894